1. |
Ingemarsson I, Lamont RF. An update on the controversies of tocolytic therapy for the prevention of preterm birth. Acta Obstet Gynecol Scand, 2003, 82(1):1-9.
|
2. |
Oei SG. Calcium channel blockers for tocolysis:a review of their role and safety following reports of serious adverse events. Eur J Obstet Gynecol Reprod Biol, 2006, 126(2):137-145.
|
3. |
Shim JY, Park YW, Yoon BH, et al. Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women. BJOG, 2006, 113(11):1228-1134.
|
4. |
Vaast P, Dubreucq-Fossaert S, Houfflin-Debarge V, et al. Acute pulmonary oedema during nicardipine therapy for premature labour; Report of five cases. Eur J Obstet Gynecol Reprod Biol, 2004, 113(1):98-99.
|
5. |
Husslein P, Quartarolo JP. Review of clinical experience with atosiban and the Tractocile Efficacy Assessment Survey in Europe (TREASURE) study protocol. Int J Clin Pract, 2003, 57(2):121-127.
|
6. |
Husslein P, Cabero RL, Dudenhausen JW, et al. Atosiban versus usual care for the management of preterm labor. J Perinat Med, 2007, 35(4):305-313.
|
7. |
Moutquin JM, Sherman D, Cohen H, et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor:a multicenter effectiveness and safety study. Am J Obstet Gynecol, 2000, 182(5):1191-1199.
|
8. |
Lin CH, Lin SY, Shyu MK, et al. Randomized trial of oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of spontaneous preterm labor in Taiwanese women. J Formos Med Assoc, 2009, 108(6):493-501.
|
9. |
Moutquin JM, Fontain JY, Dansereau J, et al. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group. BJOG, 2001, 108(2):133-142.
|
10. |
Nicholas M, Andrew A, Alan D, et al. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study. Acta Obstet Gynecol Scand, 2001, 80(5):413-422.
|
11. |
Nonnenmacher A, Hopp H, Dudenhausen J. Effectiveness and safety of atosiban vs. pulsatile administration of fenoterol in the treatment of preterm labour. Z Geburtshilfe Neonatol, 2009, 213(5):201-206.
|
12. |
Cabrol D, Gillet JY, Madelenat P, et al. Treatment of preterm labor with the oxytocin antagonist atosiban:a double-blind, randomized, controlled comparison with salbutamol. Eur J Obstet Gynecol Reprod Biol, 2001, 98(2):177-185.
|
13. |
Romero R, Sibai BM, Sanchez-Ramos L, et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor:a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol, 2000, 182(5):1173-1183.
|
14. |
Kashanian M, Akbarian AR, Soltanzadeh M. Atosiban and nifedipin for the treatment of preterm labor. Int J Gynaecol Obstet, 2005, 91(1):10-14.
|
15. |
Al-Omari WR, Al-Shammaa HB, Al-Tikriti EM, et al. Atosiban and nifedipine in acute tocolysis:a comparative study. Eur J Obstet Gynecol Reprod Biol, 2006, 128(1-2):129-134.
|
16. |
Salim R, Garmi G, Nachum Z, et al. Nifedipine compared with atosiban for treating preterm labor:a randomized controlled trial. Obstet Gynecol, 2012, 120(6):1323-1331.
|
17. |
van Geijn HP, Lenglet JE, Bolte AC. Nifedipine trials:effectiveness and safety aspects. BJOG, 2005, 112(Suppl):179-183.
|
18. |
Nakajima Y, Masaoka N, Tsuduki Y, et al. Rhabdomyolysis caused by tocolytic therapy with oral ritodrine hydrochloride in a pregnant woman with placenta previa. J Obstet Gynaecol Res, 2011, 37(6):629-632.
|
19. |
Shiba M, Kido K, Umezawa K, et al. Erythematous and bullous rash strongly indicating toxic epidermal necrolysis associated with the use of intravenous ritodrine hydrochloride. J Obstet Gynaecol Res, 2010, 36(3):676-680.
|
20. |
Yasuda R, Makino Y, Matsuda Y, et al. Agranulocytosis associated with intravenous ritodrine hydrochloride therapy:two case reports by different mechanisms. J Obstet Gynaecol Res, 2012, 38(3):574-577.
|
21. |
Wex J, Abou-Setta AM, Clerici G, et al. Atosiban versus betamimetics in the treatment of preterm labour in Italy:clinical and economic importance of side-effects. Eur J Obstet Gynecol Reprod Biol, 2011, 157(4):128-135.
|
22. |
吴远萍, 张少璇, 王雪云.醋酸阿托西班治疗先兆早产的疗效观察及护理.中国实用医药, 2010, 5(19):182-183.
|
23. |
Higgins JPT, Altman DG, Sterne JAC, et al. Charpter 8:Assessing risk of bias in included studies. In:Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collabration, 2011. Available from:www.cochrane-handbook.org.
|